Oncolytics Biotech's Earnings Outlook
Portfolio Pulse from Benzinga Insights
Oncolytics Biotech (NASDAQ:ONCY) is set to release its quarterly earnings report on November 3, 2023. Analysts estimate an earnings per share (EPS) of $-0.10. The company's past performance shows a mixed trend of beating and missing EPS estimates, with corresponding changes in share price. The company's shares are currently trading at $1.62 and have seen a 41.27% increase over the last 52-week period.
November 02, 2023 | 7:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Oncolytics Biotech is expected to report an EPS of $-0.10 in its upcoming earnings report. The company's stock price has shown a positive trend over the last year, increasing by 41.27%.
The upcoming earnings report is a significant event for Oncolytics Biotech. While the estimated EPS is negative, the company's stock has shown a positive trend over the last year. However, the company's past performance shows a mixed trend of beating and missing EPS estimates, which makes it difficult to predict the short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100